Product Details
- Trelegy Ellipta 100/62.5/25 mcg is a prescription inhalation powder used once daily for long-term maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma in adults.
- The inhaler combines fluticasone furoate, umeclidinium, and vilanterol in a single Ellipta device to help improve breathing and reduce symptoms such as wheezing, coughing, and shortness of breath.
- This 100/62.5/25 mcg strength is the only Trelegy strength approved for COPD and is supplied as a 30-dose inhaler with an integrated dose counter.
- Trelegy Ellipta is not intended to relieve sudden breathing problems and does not replace a fast-acting rescue inhaler.
Key Features:
- Triple Therapy Combination: Contains fluticasone furoate (inhaled corticosteroid), umeclidinium (long-acting muscarinic antagonist), and vilanterol (long-acting beta2-adrenergic agonist) to address airway inflammation and bronchoconstriction.
- Once-Daily Dosing: Designed for one inhalation once daily at the same time each day to support consistent maintenance control of COPD and asthma.
- COPD-Approved Strength: The 100/62.5/25 mcg strength is specifically approved for the maintenance treatment of moderate to severe COPD, including chronic bronchitis and emphysema.
- Inhalation Powder Form: Delivered as a dry powder via the Ellipta inhaler, providing targeted delivery of medication directly to the lungs.
- 30-Dose Ellipta Inhaler: Features a built-in dose counter that starts at 30 and counts down with each use, helping patients monitor remaining doses.
- Clear Use Technique: Mouthpiece design and simple slide-open mechanism with an audible click help indicate when the dose is ready for inhalation.
- Mouth Rinse Recommendation: Patients are advised to rinse their mouth with water and spit it out after use to help reduce the risk of oral thrush.
- Safety Profile: Includes important safety information such as not using for sudden breathing problems, avoiding use in children under 18 years, and contraindication in patients with severe allergy to milk proteins or any ingredients.
- Inactive Ingredients: Formulation includes lactose monohydrate (contains milk proteins) and magnesium stearate as inactive components.
- Prescription-Only Medicine: Classified as a prescription product that should be used under medical supervision, with guidance on interactions and monitoring for side effects such as pneumonia, thrush, and cardiovascular effects.
